APO Research, Inc.

APO RESEARCH · REPORT

Palonosetron Hydrochloride Injection

Selected research

Market Structure

Global Palonosetron Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Palonosetron Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Palonosetron Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Palonosetron Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Palonosetron Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Palonosetron Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Palonosetron Hydrochloride Injection include Chia Tai Tianqing Pharmaceutical, Yangtze River Pharmaceutical, Qilu Pharmaceutical, Sichuan Kelun Pharmaceutical, Hangzhou Jiuyuan Genetic, Jiangsu Aosaikang Pharmaceutical, Otsuka Pharmaceutical, Juniper Biologics and Intas Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Palonosetron Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Palonosetron Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Palonosetron Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Palonosetron Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Palonosetron Hydrochloride Injection Segment by Company

Chia Tai Tianqing Pharmaceutical

Yangtze River Pharmaceutical

Qilu Pharmaceutical

Sichuan Kelun Pharmaceutical

Hangzhou Jiuyuan Genetic

Jiangsu Aosaikang Pharmaceutical

Otsuka Pharmaceutical

Juniper Biologics

Intas Pharmaceuticals

Helsinn

Fresenius

Dr Reddy's Laboratories

Palonosetron Hydrochloride Injection Segment by Type

1.5ml

5ml

Palonosetron Hydrochloride Injection Segment by Application

Hospital

Pharmacy

Other

Palonosetron Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Palonosetron Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Palonosetron Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Palonosetron Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Palonosetron Hydrochloride Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Palonosetron Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Palonosetron Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Palonosetron Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Palonosetron Hydrochloride Injection Industry Trends Table 2. Palonosetron Hydrochloride Injection Industry Drivers Table 3. Palonosetron Hydrochloride Injection Industry Opportunities and Challenges Table 4. Palonosetron Hydrochloride Injection Industry Restraints Table 5. Global Palonosetron Hydrochloride Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Palonosetron Hydrochloride Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Palonosetron Hydrochloride Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Palonosetron Hydrochloride Injection Sales Market Share by Manufacturers Table 9. Global Palonosetron Hydrochloride Injection Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Palonosetron Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Palonosetron Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Palonosetron Hydrochloride Injection Manufacturers, Product Type & Application Table 13. Global Palonosetron Hydrochloride Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Palonosetron Hydrochloride Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1.5ml Table 17. Major Manufacturers of 5ml Table 18. Global Palonosetron Hydrochloride Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Palonosetron Hydrochloride Injection Sales by Type (2021-2026) & (k units) Table 20. Global Palonosetron Hydrochloride Injection Sales by Type (2027-2032) & (k units) Table 21. Global Palonosetron Hydrochloride Injection Sales Market Share by Type (2021-2026) Table 22. Global Palonosetron Hydrochloride Injection Sales Market Share by Type (2027-2032) Table 23. Global Palonosetron Hydrochloride Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Palonosetron Hydrochloride Injection Revenue by Type (2021-2026) & (k units) Table 25. Global Palonosetron Hydrochloride Injection Revenue by Type (2027-2032) & (k units) Table 26. Global Palonosetron Hydrochloride Injection Revenue Market Share by Type (2021-2026) Table 27. Global Palonosetron Hydrochloride Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Other Table 31. Global Palonosetron Hydrochloride Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Palonosetron Hydrochloride Injection Sales by Application (2021-2026) & (k units) Table 33. Global Palonosetron Hydrochloride Injection Sales by Application (2027-2032) & (k units) Table 34. Global Palonosetron Hydrochloride Injection Sales Market Share by Application (2021-2026) Table 35. Global Palonosetron Hydrochloride Injection Sales Market Share by Application (2027-2032) Table 36. Global Palonosetron Hydrochloride Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Palonosetron Hydrochloride Injection Revenue by Application (2021-2026) & (k units) Table 38. Global Palonosetron Hydrochloride Injection Revenue by Application (2027-2032) & (k units) Table 39. Global Palonosetron Hydrochloride Injection Revenue Market Share by Application (2021-2026) Table 40. Global Palonosetron Hydrochloride Injection Revenue Market Share by Application (2027-2032) Table 41. Global Palonosetron Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Palonosetron Hydrochloride Injection Sales by Region (2021-2026) & (k units) Table 43. Global Palonosetron Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 44. Global Palonosetron Hydrochloride Injection Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Palonosetron Hydrochloride Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Palonosetron Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Palonosetron Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 48. North America Palonosetron Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 49. Europe Palonosetron Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Palonosetron Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 51. Europe Palonosetron Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Palonosetron Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Palonosetron Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Palonosetron Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Palonosetron Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Palonosetron Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Palonosetron Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 58. Global Palonosetron Hydrochloride Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Palonosetron Hydrochloride Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Palonosetron Hydrochloride Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Palonosetron Hydrochloride Injection Revenue Market Share by Region (2021-2026) Table 62. Global Palonosetron Hydrochloride Injection Revenue Market Share by Region (2027-2032) Table 63. Chia Tai Tianqing Pharmaceutical Company Information Table 64. Chia Tai Tianqing Pharmaceutical Business Overview Table 65. Chia Tai Tianqing Pharmaceutical Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chia Tai Tianqing Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio Table 67. Chia Tai Tianqing Pharmaceutical Recent Development Table 68. Yangtze River Pharmaceutical Company Information Table 69. Yangtze River Pharmaceutical Business Overview Table 70. Yangtze River Pharmaceutical Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Yangtze River Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio Table 72. Yangtze River Pharmaceutical Recent Development Table 73. Qilu Pharmaceutical Company Information Table 74. Qilu Pharmaceutical Business Overview Table 75. Qilu Pharmaceutical Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qilu Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio Table 77. Qilu Pharmaceutical Recent Development Table 78. Sichuan Kelun Pharmaceutical Company Information Table 79. Sichuan Kelun Pharmaceutical Business Overview Table 80. Sichuan Kelun Pharmaceutical Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sichuan Kelun Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio Table 82. Sichuan Kelun Pharmaceutical Recent Development Table 83. Hangzhou Jiuyuan Genetic Company Information Table 84. Hangzhou Jiuyuan Genetic Business Overview Table 85. Hangzhou Jiuyuan Genetic Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hangzhou Jiuyuan Genetic Palonosetron Hydrochloride Injection Product Portfolio Table 87. Hangzhou Jiuyuan Genetic Recent Development Table 88. Jiangsu Aosaikang Pharmaceutical Company Information Table 89. Jiangsu Aosaikang Pharmaceutical Business Overview Table 90. Jiangsu Aosaikang Pharmaceutical Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jiangsu Aosaikang Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio Table 92. Jiangsu Aosaikang Pharmaceutical Recent Development Table 93. Otsuka Pharmaceutical Company Information Table 94. Otsuka Pharmaceutical Business Overview Table 95. Otsuka Pharmaceutical Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Otsuka Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio Table 97. Otsuka Pharmaceutical Recent Development Table 98. Juniper Biologics Company Information Table 99. Juniper Biologics Business Overview Table 100. Juniper Biologics Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Juniper Biologics Palonosetron Hydrochloride Injection Product Portfolio Table 102. Juniper Biologics Recent Development Table 103. Intas Pharmaceuticals Company Information Table 104. Intas Pharmaceuticals Business Overview Table 105. Intas Pharmaceuticals Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Intas Pharmaceuticals Palonosetron Hydrochloride Injection Product Portfolio Table 107. Intas Pharmaceuticals Recent Development Table 108. Helsinn Company Information Table 109. Helsinn Business Overview Table 110. Helsinn Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Helsinn Palonosetron Hydrochloride Injection Product Portfolio Table 112. Helsinn Recent Development Table 113. Fresenius Company Information Table 114. Fresenius Business Overview Table 115. Fresenius Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Fresenius Palonosetron Hydrochloride Injection Product Portfolio Table 117. Fresenius Recent Development Table 118. Dr Reddy's Laboratories Company Information Table 119. Dr Reddy's Laboratories Business Overview Table 120. Dr Reddy's Laboratories Palonosetron Hydrochloride Injection Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Dr Reddy's Laboratories Palonosetron Hydrochloride Injection Product Portfolio Table 122. Dr Reddy's Laboratories Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Palonosetron Hydrochloride Injection Distributors List Table 126. Palonosetron Hydrochloride Injection Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Palonosetron Hydrochloride Injection Product Image Figure 2. Global Palonosetron Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Palonosetron Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Palonosetron Hydrochloride Injection Sales (2021-2032) & (k units) Figure 5. Global Palonosetron Hydrochloride Injection Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Palonosetron Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1.5ml Image Figure 9. 5ml Image Figure 10. Global Palonosetron Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Palonosetron Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Palonosetron Hydrochloride Injection Sales Market Share by Type (2021-2032) Figure 13. Global Palonosetron Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Palonosetron Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Palonosetron Hydrochloride Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Pharmacy Image Figure 18. Other Image Figure 19. Global Palonosetron Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Palonosetron Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Palonosetron Hydrochloride Injection Sales Market Share by Application (2021-2032) Figure 22. Global Palonosetron Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Palonosetron Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Palonosetron Hydrochloride Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Palonosetron Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Palonosetron Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Palonosetron Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 39. China Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Palonosetron Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Palonosetron Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Palonosetron Hydrochloride Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Palonosetron Hydrochloride Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Palonosetron Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Palonosetron Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Palonosetron Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Palonosetron Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Palonosetron Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Palonosetron Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Palonosetron Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Palonosetron Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Palonosetron Hydrochloride Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Palonosetron Hydrochloride Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 1.5ml
  • 5ml
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • Yangtze River Pharmaceutical
  • Qilu Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Hangzhou Jiuyuan Genetic
  • Jiangsu Aosaikang Pharmaceutical
  • Otsuka Pharmaceutical
  • Juniper Biologics
  • Intas Pharmaceuticals
  • Helsinn
  • Fresenius
  • Dr Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Palonosetron Hydrochloride Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Palonosetron Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Palonosetron Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Palonosetron Hydrochloride Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Palonosetron Hydrochloride Injection Market Dynamics
  1. 2.1 Palonosetron Hydrochloride Injection Industry Trends
  2. 2.2 Palonosetron Hydrochloride Injection Industry Drivers
  3. 2.3 Palonosetron Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Palonosetron Hydrochloride Injection Industry Restraints
3 Palonosetron Hydrochloride Injection Market by Manufacturers
  1. 3.1 Global Palonosetron Hydrochloride Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Palonosetron Hydrochloride Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Palonosetron Hydrochloride Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Palonosetron Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Palonosetron Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Palonosetron Hydrochloride Injection Manufacturers, Product Type & Application
  7. 3.7 Global Palonosetron Hydrochloride Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Palonosetron Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Palonosetron Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Palonosetron Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Palonosetron Hydrochloride Injection Market by Type
  1. 4.1 Palonosetron Hydrochloride Injection Type Introduction
  2. 4.1.1 1.5ml
  3. 4.1.2 5ml
  4. 4.2 Global Palonosetron Hydrochloride Injection Sales by Type
  5. 4.2.1 Global Palonosetron Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Palonosetron Hydrochloride Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Palonosetron Hydrochloride Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Palonosetron Hydrochloride Injection Revenue by Type
  9. 4.3.1 Global Palonosetron Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Palonosetron Hydrochloride Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Palonosetron Hydrochloride Injection Revenue Market Share by Type (2021-2032)
5 Palonosetron Hydrochloride Injection Market by Application
  1. 5.1 Palonosetron Hydrochloride Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Palonosetron Hydrochloride Injection Sales by Application
  6. 5.2.1 Global Palonosetron Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Palonosetron Hydrochloride Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Palonosetron Hydrochloride Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Palonosetron Hydrochloride Injection Revenue by Application
  10. 5.3.1 Global Palonosetron Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Palonosetron Hydrochloride Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Palonosetron Hydrochloride Injection Revenue Market Share by Application (2021-2032)
6 Global Palonosetron Hydrochloride Injection Sales by Region
  1. 6.1 Global Palonosetron Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Palonosetron Hydrochloride Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Palonosetron Hydrochloride Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Palonosetron Hydrochloride Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Palonosetron Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Palonosetron Hydrochloride Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Palonosetron Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Palonosetron Hydrochloride Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Palonosetron Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Palonosetron Hydrochloride Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Palonosetron Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Palonosetron Hydrochloride Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Palonosetron Hydrochloride Injection Revenue by Region
  1. 7.1 Global Palonosetron Hydrochloride Injection Revenue by Region
  2. 7.1.1 Global Palonosetron Hydrochloride Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Palonosetron Hydrochloride Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Palonosetron Hydrochloride Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Palonosetron Hydrochloride Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Palonosetron Hydrochloride Injection Revenue (2021-2032)
  8. 7.2.2 North America Palonosetron Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Palonosetron Hydrochloride Injection Revenue (2021-2032)
  11. 7.3.2 Europe Palonosetron Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Palonosetron Hydrochloride Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Palonosetron Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Palonosetron Hydrochloride Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Palonosetron Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chia Tai Tianqing Pharmaceutical
  2. 8.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 8.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 8.1.3 Chia Tai Tianqing Pharmaceutical Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chia Tai Tianqing Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio
  6. 8.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 8.2 Yangtze River Pharmaceutical
  8. 8.2.1 Yangtze River Pharmaceutical Company Information
  9. 8.2.2 Yangtze River Pharmaceutical Business Overview
  10. 8.2.3 Yangtze River Pharmaceutical Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangtze River Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio
  12. 8.2.5 Yangtze River Pharmaceutical Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Sichuan Kelun Pharmaceutical
  20. 8.4.1 Sichuan Kelun Pharmaceutical Company Information
  21. 8.4.2 Sichuan Kelun Pharmaceutical Business Overview
  22. 8.4.3 Sichuan Kelun Pharmaceutical Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Kelun Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio
  24. 8.4.5 Sichuan Kelun Pharmaceutical Recent Developments
  25. 8.5 Hangzhou Jiuyuan Genetic
  26. 8.5.1 Hangzhou Jiuyuan Genetic Company Information
  27. 8.5.2 Hangzhou Jiuyuan Genetic Business Overview
  28. 8.5.3 Hangzhou Jiuyuan Genetic Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hangzhou Jiuyuan Genetic Palonosetron Hydrochloride Injection Product Portfolio
  30. 8.5.5 Hangzhou Jiuyuan Genetic Recent Developments
  31. 8.6 Jiangsu Aosaikang Pharmaceutical
  32. 8.6.1 Jiangsu Aosaikang Pharmaceutical Company Information
  33. 8.6.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  34. 8.6.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Aosaikang Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio
  36. 8.6.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  37. 8.7 Otsuka Pharmaceutical
  38. 8.7.1 Otsuka Pharmaceutical Company Information
  39. 8.7.2 Otsuka Pharmaceutical Business Overview
  40. 8.7.3 Otsuka Pharmaceutical Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Otsuka Pharmaceutical Palonosetron Hydrochloride Injection Product Portfolio
  42. 8.7.5 Otsuka Pharmaceutical Recent Developments
  43. 8.8 Juniper Biologics
  44. 8.8.1 Juniper Biologics Company Information
  45. 8.8.2 Juniper Biologics Business Overview
  46. 8.8.3 Juniper Biologics Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Juniper Biologics Palonosetron Hydrochloride Injection Product Portfolio
  48. 8.8.5 Juniper Biologics Recent Developments
  49. 8.9 Intas Pharmaceuticals
  50. 8.9.1 Intas Pharmaceuticals Company Information
  51. 8.9.2 Intas Pharmaceuticals Business Overview
  52. 8.9.3 Intas Pharmaceuticals Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Intas Pharmaceuticals Palonosetron Hydrochloride Injection Product Portfolio
  54. 8.9.5 Intas Pharmaceuticals Recent Developments
  55. 8.10 Helsinn
  56. 8.10.1 Helsinn Company Information
  57. 8.10.2 Helsinn Business Overview
  58. 8.10.3 Helsinn Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Helsinn Palonosetron Hydrochloride Injection Product Portfolio
  60. 8.10.5 Helsinn Recent Developments
  61. 8.11 Fresenius
  62. 8.11.1 Fresenius Company Information
  63. 8.11.2 Fresenius Business Overview
  64. 8.11.3 Fresenius Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fresenius Palonosetron Hydrochloride Injection Product Portfolio
  66. 8.11.5 Fresenius Recent Developments
  67. 8.12 Dr Reddy's Laboratories
  68. 8.12.1 Dr Reddy's Laboratories Company Information
  69. 8.12.2 Dr Reddy's Laboratories Business Overview
  70. 8.12.3 Dr Reddy's Laboratories Palonosetron Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dr Reddy's Laboratories Palonosetron Hydrochloride Injection Product Portfolio
  72. 8.12.5 Dr Reddy's Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Palonosetron Hydrochloride Injection Value Chain Analysis
  2. 9.1.1 Palonosetron Hydrochloride Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Palonosetron Hydrochloride Injection Production Mode & Process
  6. 9.2 Palonosetron Hydrochloride Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Palonosetron Hydrochloride Injection Distributors
  9. 9.2.3 Palonosetron Hydrochloride Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.